[Effect of pravastatin on cholesteryl esters in foam cells and the relation with caveolin-1].
The purpose of the present study was to investigate the effect of pravastatin on cholesteryl esters in foam cells of murine macrophages and the relation with caveolin-1. RAW 264.7 murine macrophages were coincubated with 80 mg/L oxidized low density lipoprotein (ox-LDL) and pravastatin (0~100 mumol/L) respectively for 24 h. When the best control concentration of pravastatin was confirmed, RAW 264.7 murine macrophages were coincubated with 80 mg/L ox-LDL and pravastatin of the best concentration respectively for 0, 6, 12, 24 h. Oil red O dyeing experiment was used to show the lipid droplets in foam cells. High performance liquid chromatography (HPLC) analysis was performed to determine the content of cellular cholesterol. The level of caveolin-1 was determined by Western blot analysis. The result showed that when macrophages were incubated with 80 mg/L ox-LDL, the ratio of cellular cholesteryl ester to total cholesterol (CE/TC) was beyond 50% through HPLC analysis, and a great deal of lipid droplets displayed in cells through Oil red O dyeing experiment, which manifested the formation of the foam cells. Pravastatin could decrease CE in foam cells in a concentration-dependent manner (1~100 mumol/L). At the concentration of 100 mumol/L, pravastatin decreased cellular CE more than 50%. The effects of pravastatin on the decrease of CE in murine macrophages also displayed a time-dependent manner (incubated with 100 mumol/L pravastatin from 6 to 24 h). Moreover, the expression of caveolin-1 was decreased when the macrophages were incubated with ox-LDL (80 mg/L), while treatment with pravastatin increased the level of caveolin-1 and displayed a concentration- and time-dependent manner. These results suggest that pravastatin could inhibit the development of foam cells through the decrease of cellular CE, which may be related to the upregulation of caveolin-1.
Qin
Li
L
Institute of Pharmacy and Pharmacology, Nanhua University, Hengyang 421001, China.
Qin
Xu-Ping
XP
Wang
Zuo
Z
Zhu
Bing-Yang
BY
Liao
Duan-Fang
DF
D000818:Animals; D000924:Anticholesteremic Agents / Q000494:pharmacology; D051242:Caveolin 1 / Q000378:metabolism*; D002460:Cell Line; D002478:Cells, Cultured; D002788:Cholesterol Esters / Q000378:metabolism*; D005487:Foam Cells / Q000378:metabolism*; D008077:Lipoproteins, LDL / Q000494:pharmacology; D008264:Macrophages / Q000166:cytology*; D017035:Pravastatin / Q000494:pharmacology*; D051381:Rats
D000924:Anticholesteremic Agents; D051242:Caveolin 1; D002788:Cholesterol Esters; D008077:Lipoproteins, LDL; C099252:oxidized low density lipoprotein; D017035:Pravastatin